Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer
Sunday, October 10, 2010 - 09:20
in Health & Medicine
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy...